EVALUATION OF THE STATE OF THE IMMUNE STATUS IN PATIENTS WITH BREAST CANCER WITH THE DETERMINATION OF THE EFFECTIVENESS OF NEOADJUVANT POLYCHEMOTHERAPY

YOROV Lutfillo Shukrilloevich, DJURAEV Mirjalol Dexkanovich, RAXIMOV Nodir Maxammatkulovich, SHAXANOVA Shaxnoza Shavkatovna

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali · 2022-yil

Annotatsiya

Therapy for breast cancer is due to the presence of aggressive biological types of tumors that require multiple, expensive chemotherapy regimens, even in the early stages of the process.  In recent years, such a direction as MN immunotherapy has been developing, which is aimed at inhibiting tumor growth and stimulating the body's antitumor immune response.  Carrying out immunocorrection in patients with breast cancer with Her-2 positive status has great prospects in oncological practice, due to the possibility of reducing the side effects of tumor and chemoradiation intoxication, as well as activating the own antitumor defense system.  Determination of the optimal immunomodulatory drugs, the sequence of various effects on the immune system, and their impact on the results of anticancer therapy require further research.

Maqola ma’lumotlari
MualliflarYOROV Lutfillo Shukrilloevich, DJURAEV Mirjalol Dexkanovich, RAXIMOV Nodir Maxammatkulovich, SHAXANOVA Shaxnoza Shavkatovna
JurnalJournal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali
Nashr sanasi2022-12-09
Jild7
Son5
TilRus

Kalit so‘zlar

рак молочной железы, иммунный статус, неоадъювантная полихимиотерапия, breast cancer, immune status, neoadjuvant polychemotherapy, sut bezi saratoni, immun tizim, neoadyuvant poliximioterapiya

Ilmiy soha

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali jurnalidan boshqa maqolalar

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali — barcha maqolalar